ÂÜÀòÂÒÂ×

Thomas Kuilman is an accomplished scientific professional with extensive experience in immunology, bioinformatics, and molecular biology. Currently serving as the Director of TCR Discovery & Bioinformatics at Neogene Therapeutics since January 2019, Kuilman has progressively advanced through various roles including Associate Director and Principal Scientist. Prior experience includes a senior postdoctoral fellowship at The Netherlands Cancer Institute, where Kuilman investigated cancer drug responses through integrative approaches. Kuilman's postdoctoral tenure at the London Research Institute focused on protein dynamics during cell division, complemented by a PhD at The Netherlands Cancer Institute that led to significant findings in tumor-suppressive mechanisms published in notable journals. Kuilman holds an MSc in Chemistry from Vrije Universiteit Amsterdam.